Skip to main content
OpenTrials
Completed

NCT Number: NCT02032914

Prevalence of Colon Cancer in Pyogenic Liver Abscess

Although a proportion of pyogenic liver abscess may originated from colonic mucosal lesions, the prevalence of colonic neoplasm in the patients with pyogenic liver abscess are still not evaluated yet. Thus, our group will find the prevalence of colonic neoplasm in the group of cryptogenic pyogenic liver abscess by colonoscopic examination.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cryptogenic Pyogenic Liver Abscess Abdominal Abscess Abscess Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Infections Intestinal Diseases Intestinal Neoplasms Liver Abscess Liver Abscess, Pyogenic Liver Diseases Neoplasms Neoplasms by Site Suppuration

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Pusan National Unversity Yangsan Hospital, Yangsan, Gyeongsangnam-do, South Korea

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pyogenic liver abscess radiologically and bacteriologically diagnosed

Exclusion criteria

  • Amebic liver abscess
  • Other causes of pyogenic liver abscess such as cholangitis, liver cancer, complication of transarterial chemoembolization or radiofrequency ablation to hepatocellular carcinoma
  • Refusal to colonoscopic examination
  • Inadequate general patient status to perform the colonoscopic examination
  • Patient who has had the screening colonoscopic examination within 1 year and showed normal finding or had 1 or 2 colon polyp in adequate exam

Treatment and study plan

Primary outcomes

  1. The prevalence of colonic neoplasm

    Time frame: within 6 weeks after diagnosis of pyogenic liver abscess

Secondary outcomes

  1. Prevalence of colon polyp

    Time frame: Within 6 weeks at diagnosis of pyogenic liver abscess

  2. Prevalence of colonic diverticulitis

    Time frame: Within 6 weeks at diagnosis of pyogenic liver abscess

  3. Prevalence of inflammatory bowel disease

    Time frame: Within 6 weeks at diagnosis of pyogenic liver abscess

  4. Prevalence of intestinal tuberculosis

    Time frame: Within 6 weeks at diagnosis of pyogenic liver abscess

Sponsors and collaborators

Lead sponsor

Inje University

Other

Collaborators

  • Pusan National University Yangsan Hospital

Registry information

Official study title

The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Jan 10, 2014
Registry last updated
Mar 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.